Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 9 years
- Director since
- 2023
9 years of board service in total across 3 boards, counting each seat separately. Longest: Organon & Co., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Fulcrum Therapeutics Inc. June 24, 202697.3%
-
Organon & Co. June 9, 202697.1%
-
Organon & Co. June 10, 202597.7%
-
Fulcrum Therapeutics Inc. June 8, 202382.2%
-
Organon & Co. June 6, 202399.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 26, 2026 | Fulcrum Therapeutics Inc. | Open-market sale | −18,000 | $3.65 | $65,700 |
| Mar 7, 2025 | Septerna Inc. | Open-market purchase | +13,319 | $6.93 | $92,301 |
| Mar 6, 2025 | Septerna Inc. | Open-market purchase | +41,355 | $6.00 | $248,130 |
| Mar 5, 2025 | Septerna Inc. | Open-market purchase | +37,835 | $5.82 | $220,200 |
| Mar 4, 2025 | Septerna Inc. | Open-market purchase | +7,491 | $6.35 | $47,568 |
Questions about Alan Ezekowitz
What boards is Alan Ezekowitz on?
Alan Ezekowitz sits on the boards of Fulcrum Therapeutics Inc., Organon & Co. and Septerna Inc.
How long has Alan Ezekowitz served on boards?
Our records show at least 9 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.